Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Therapeutic response of metastatic angiomatoid fibrous histiocytoma carrying EWSR1-CREB1 fusion to the interleukin-6 receptor antibody tocilizumab
Samara L. Potter
, Norma M. Quintanilla
, Danielle K. Johnston
,
Bindi Naik-Mathuria
, Rajkumar Venkatramani
Research output
:
Contribution to journal
›
Article
›
peer-review
15
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Therapeutic response of metastatic angiomatoid fibrous histiocytoma carrying EWSR1-CREB1 fusion to the interleukin-6 receptor antibody tocilizumab'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Treatment Response
100%
Interleukin 6 Receptor
100%
Interleukin 6
100%
Receptor Antibody
100%
Dermatofibroma
100%
Tocilizumab
100%
Secretion (Process)
66%
Targeted Therapy
66%
Neoplasm
33%
Tumor Progression
33%
Gene Fusion
33%
Distant Metastasis
33%
Soft Tissue Tumor
33%
Tumor
33%
Diseases
33%
Keyphrases
Interleukin-6
100%
Therapeutic Response
100%
Interleukin-6 Inhibitors
100%
Tocilizumab
100%
Angiomatoid Fibrous Histiocytoma
100%
EWSR1-CREB1 Fusion
100%
Targeted Therapy
66%
Tumor Growth
33%
Tumor
33%
Neoplasms
33%
Potential Gains
33%
Gene Fusion
33%
Distant Metastasis
33%
Soft Tissue Tumor
33%
EWSR1-CREB1
33%
CREB1 Gene
33%